Veli-Matti Leppänen

Person

Latest publications

  1. Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

    Crona, D. J., Skol, A. D., Leppänen, V-M., Glubb, D. M., Etheridge, A. S., Hilliard, E., Pena, C. E., Peterson, Y. K., Klauber-DeMore, N., Alitalo, K. K. & Innocenti, F., 1 Jan 2019, In : Cancer Research. 79, 1, p. 231-241 11 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. Vascular endothelial growth factor signaling in development and disease

    Karaman, S., Leppänen, V-M. & Alitalo, K., 15 Jul 2018, In : Development. 145, 14, 8 p., 151019.

    Research output: Contribution to journalArticleScientificpeer-review

View all (35) »

ID: 61991